baber/WOPTO huggingface dataset:
Patent NZ-330394-A (NZ)
Title: Lead-acid battery with handle having an arm adjacent a grip area having a pin-and button structure for attaching to a cover
Inventor: HORTON ANTHONY R
IPC: H01M10/06
Filed: 1998-05-08
Abstract: n electric storage battery comprises a container having side and end walls, a cover having opposed side and end walls attached to the respective side and end walls of the container and a handle 20 attached to the container and having an arm 30 adjacent a user grip area.  Each arm 30 has a pin 44 (not labelled) and button 46 (not labelled) structure for attaching handle to the container.  The container has two sets of handle attachment structures comprising pockets moulded into the container each having an insertion aperture forming an insertion position for attaching handle to the container and an assembly aperture forming an assembly position for the attached handle.  The insertion apertures are complementally sized to accept therethrough handle arm buttons and the pockets are sized to allow movement of buttons from the insertion position to the assembly position.  The pins each have a cross section allowing movement of the pins from the insertion position to the assembly position and buttons from the insertion aperture to the assembly aperture.  The button is not present in the assembly aperture when the pin is in the insertion aperture.  The button and assembly position apertures are complementally sized such that the buttons cannot be pulled out through assembly aperture when handle is in the assembly position.  Handle 20 in the assembly position is rotated from a rest position adjacent an end or side wall of container to an upright service position rotation from the rest position to the service position rotating the handle arm pins such that the cross-sectional configuration of each pin resists movement of handle 20 from the assembly position to the insertion position.
Patent NZ-334925-A (NZ)
Title: Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing using 2-(4'-bromobiphenyl-4-sulfonylamino)-3-methyl-butyric acid and 4-(4'-chloro-biphenyl-4-yl)-4-hydroxyimino-butyric acid
Inventor: BOCAN THOMAS MICHAEL ANDREW
IPC: A61K9/06
Filed: 1997-11-21
Abstract: The use of a matrix metalloproteinase inhibitor of the compound described for treating or preventing neurological disorder. Wherein; R1 is C1-6alkyl, halo, nitro, NR4R5, cyano, OR4 and COOR4; R2 is C1-6alkyl, optionally substituted by phenyl, substituted phenyl, NR4R5, OR6, carboxy, carboxamido, H2N-C(NH)-NH-, thio, methylthio, indole, imidazole, phthalimido, phenyl, and substituted phenyl; R3 is OH, OC1-6alkyl or NHOH; R4 is hydrogen, C1-6alkyl or C1-6alkanoyl; R5 is hydrogen or C1-6alkyl; and R6 is hydrogen, C1-6alkyl, C1-6alkanoyl, phenyl or substituted phenyl.
Patent NZ-336783-A (NZ)
Title: A shearing handpiece having a clamp plate with a projection that fits into a recess
Inventor: HARWARD RICHARD
IPC: B26B19/24
Filed: 1999-07-15
Abstract: A comb assembly 10 to be mounted on a body of a handpiece to cut hair, has a comb 12 with an alignment recess 15 - not shown and a clamp plate 13 having a projection 14 received within recess 15 but having a clearance with respect thereto to provide for adjustment of the lead and throw of the comb relative to clamp plate 13.  Clamp plate 13 is adapted to secure the comb to the body of the handpiece.  A threaded member has a shaft which passes through clamp plate 13 to threadably engage with the body so that upon tensioning of the threaded member, the comb is clamped to the body by clamp plate 13.  The comb and clamp plate 13 have markings 21 & 22 in the form of an array of discrete indicia, to aid in the positioning of the comb relative to clamp plate 13 and therefore an associated cutter.
Patent NZ-500740-A (NZ)
Title: Recombinant lentivirus-based gene transfer vectors comprising 3 vectors from Equine Infectious Anemia Virus (EIAV)
Inventor: OLSEN JOHN C
IPC: E05B81/32
Filed: 1998-05-12
Abstract: A recombinant lentiviral vector expression system comprises a first vector that comprises a nucleic acid sequence of at least part of the Equine Infectious Anemia Virus (EIAV) genome. The vector contains at least one defect in at least one gene encoding an EIAV structural protein, but is preferably a gag/pol expression vector. The expression system further comprises a second vector, also comprising a nucleic acid sequence of at least part of the Equine Infectious Anemia Virus (EIAV) genome, and additionally containing a multiple cloning site wherein a heterologous gene may be inserted. The expression system also comprises a third vector which expresses a viral envelope protein. The first and third vectors are packaging signal-defective. When the expression system is transfected into a lentivirus-permissive cell, replication-defective EIAV particles may be produced, which particles are useful in delivering heterologous genes to a broad range of both dividing and non-dividing cells.
Patent NZ-500840-A (NZ)
Title: Alkaline ether amine conveyor lubricant
Inventor: PERSON HEI KIMBERLEY L
IPC: C10N30/00
Filed: 1998-05-12
Abstract: An amine based lubricant concentrate which comprises; a) one or more ether amine compounds having the formulas R1-OR2-NH2, R1-OR2-NH-R3-NH2, and mixtures thereof wherein, R1 is a linear, saturated or unsaturated C6-C18 alkyl group, R2 is a linear or branched C1-C8 alkylene group and b) a non ionic surfactant effective to solubilise the ether amine compounds when diluted with water wherein the lubricant concentrate has a pH of 10 or greater. Also described are a lubricant use solution and a method of lubricating a conveyor system which involves diluting the concentrated solution with water and applying the lubricant use solution to the intended surface of use.
Patent NZ-501408-A (NZ)
Title: Carbohydrate-based enzyme granulates
Inventor: BARENDSE RUDOLF CAROLUS MARIA
IPC: A23K1/165
Filed: 1998-06-04
Abstract: A process for preparing an enzyme-containing granulate useful as an ingredient in an animal feed comprises processing an enzyme (such as phytase, endo-xylanase and/or a b-glucanase), a solid carrier comprising at least 15% (w/w) of an edible carbohydrate polymer but less than 5%(W/W) of protein and water in appropriate relative amounts to obtain enzyme containing granulates and then drying the granulates.
Patent NZ-504074-A (NZ)
Title: Iodine antimicrobial compositions containing nonionic surfactants and halogen anions
Inventor: FORET CHRIS
IPC: A01N25/30
Filed: 1998-08-06
Abstract: An iodine-based aqueous antimicrobial composition comprises amounts of available iodine as molecular iodine present at a level from 1-30% by weight as a molecular iodine, non-ionic surfactant present at a level from about 1-30% by weight and a halide ion selected from chloride and bromide ions and mixtures. The non-ionic surfactant may be polyethoxylated polyoxypropylene block copolymers, alkylphenol ethoxylates having C4-C12 alkyl groups, ethoxylated fatty alcohols and fatty acids and mixtures. Other ingredients can be a buffering agent, emollients, thickeners and wetting agents. The composition can be in the form of dilutable concentrates or final use solutions.
Patent NZ-504800-A (NZ)
Title: 6-Amino-9-benzyl-8-hydroxy-purine derivatives and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases thereof
Inventor: KURIMOTO AYUMU
IPC: C07D473/24
Filed: 1998-11-26
Abstract: The heterocyclic compound (or salt thereof) has the formula (I): wherein X is S, O, or -NR3- (in which R3 is H, alkyl or substituted alkyl, or may form an optionally substituted heterocyclic ring together with R1 via the nitrogen atom); R1 is optionally substituted alkyl, optionally substituted aryl, or optionally substituted heterocyclic; and R2 is H, or one or more substituents on the benzene ring independently selected from hydroxy, optionally substituted lower alkyl, optionally substituted lower alkoxy, optionally substituted lower alkanoyl, optionally substituted aroyl, carboxyl, optionally substituted lower alkoxycarbonyl, amino, lower alkylamino, di(lower alkyl)amino, carbamoyl, lower alkylcarbamoyl, di(lower alkyl)carbamoyl, halogen, nitro or cyano. Also described is a pharmaceutical composition comprising the compound of formula (I) or its pharmaceutically acceptable salt. Also described are interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases; which comprise the compound of formula (I) or its pharmaceutically acceptable salt.
Patent NZ-506649-A (NZ)
Title: Use of IL-12 and an antigen of a pathogen to stimulate neonatal immunity
Inventor: METZGER DENNIS W
IPC: A61K39/095
Filed: 1999-03-04
Abstract: Administration of IL-12 to a neonatal host enhances immunity and induces memory for protective responses.  It is also known that exposure of the neonate to antigens induces a specific immunological tolerance to those antigens.  Proposed is the use of IL-12 and an antigen of a pathogen for inducing an enhanced immune response to the pathogen in a neonatal host, and priming the neonatal host for a memory response to the pathogen as an adult.
Patent NZ-508770-A (NZ)
Title: Textilinin plasmin inhibitors from the Australian brown snake pseudonaja textilis textilis
Inventor: MASCI PANTALEONE PAUL
IPC: A61K38/43
Filed: 1999-05-07
Abstract: A substantially pure preparation of a single stage competitive inhibitor of plasmin comprising the amino acid sequence EECESTCAA; and its use in alleviating blood loss.
Patent NZ-509636-A (NZ)
Title: New piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them useful for treating disease caused by endothelial dysfunction
Inventor: PEGLION JEAN-LOUIS
IPC: A61P9/08
Filed: 2001-01-30
Abstract: Piperidine-4-sulphonamide compounds of formula (I), the process for their preparation and their use in treating endothelial disorders is disclosed.  Such endothelial disorders include atherosclerotic lesions, vascular complications following vascular bypass, vascular dilation, vascular repermeabilisation, heart transplant, myocardial disorders, peripheral ischaemia, cardiac insufficiency and pulmonary arterial hypertension.
Patent NZ-513024-A (NZ)
Title: Allocation of a quality of service for a packet stream by requesting service from a controller
Inventor: PREHOFER CHRISTIAN
IPC: H04L47/2416
Filed: 2000-03-08
Abstract: A method for the allocation of a quality of service for a service, which is provided in at least one communications network (KN), which transmits packets (PA) and/or packet streams (ST) in a packet-oriented manner as a function of qualities of service (DG); comprises the following steps: - use of the service is requested with a controller; - the controller allocates the quality of service for the requested use of the service as a function of the service and/or of the requested use of the service. Utilisation (NU) of the service is requested from a control (SF), which allocates a quality of service (DG) for the requested utilisation (NU) according to the service and/or the requested utilisation (NU) of the service.
Patent NZ-514141-A (NZ)
Title: Melanocortin receptor ligands
Inventor: MAZUR ADAM WIESLAW
IPC: A61P21/00
Filed: 2000-03-21
Abstract: Disclosed are compounds of Formula (I): wherein B, X, Z, D, G, R, R1, R1', R11, m, n, p, and q are as described in the specification. The compounds are useful in treating diseases that are mediated by the MC-4 and/or the MC-3 receptor. As such, the invention is directed to a manufacture of a medicament for treating disorders such as obesity, anorexia, cachexia, CNS depression, behavior-related disorders, memory-related disorders, cardiovascular function, inflammation, sepsis, septic shock, cardiogenic shock, hypovolemic shock, sexual dysfunction, erectile dysfunction, muscle atrophy, diseases associated with nerve growth and repair, and intrauterine fetal growth. Also disclosed are pharmaceutical compositions comprising the compounds of Formula (I).
Patent NZ-515267-A (NZ)
Title: Pressure control system in a water electrolytic cell
Inventor: FAIRLIE MATTHEW J
IPC: C25B15/02
Filed: 2000-04-28
Abstract: Apparatus and a process for providing oxygen and hydrogen at a desired minimum pressure from an electrolyser comprising an anolyte solution having an anolyte liquid level; a catholyte solution having a catholyte liquid level; oxygen generated at an oxygen pressure above said anolyte; hydrogen generated at a hydrogen pressure above said catholyte for passage through hydrogen outlet means; the method comprising raising the oxygen pressure above the anolyte to effect a positive liquid level pressure differential between said catholyte level and said anolyte level to a pre-selected value to effect closure of said hydrogen outlet means and an increase in the hydrogen pressure to a value to effect opening of said hydrogen outlet means to provide hydrogen at said desired minimum pressure. The hydrogen is provided on demand at a readily available pressure suitable for use, such as in the case of hydrogen in metal hydride production or supply to a compressor for subsequent higher pressure utility; and oxygen for breathing assistance and sanitization purposes. The pressure differential across the cell membrane is low or negligible, notwithstanding the hydrogen and oxygen product pressure.
Patent NZ-516989-A (NZ)
Title: Method for preparing a ruminant feed material comprising mixing a liquid feed product and a salt with a protein feedstuff to decrease nitrogen solubility
Inventor: SUMMER PAUL
IPC: A23K10/33
Filed: 2002-02-01
Abstract: A method of preparing a ruminant feed material with decreased nitrogen solubility, comprising mixing a liquid feed product containing a salt with a protein feedstuff, wherein the liquid feed product containing a salt comprises a material selected from the group consisting of condensed fermentation solubles, distiller's solubles, molasses, corn steep liquor, liquid whey and a mixture thereof, wherein the salt is a salt of ammonium, magnesium, potassium, calcium and a mixture thereof, wherein the protein feedstuff contains crude protein in an amount from 30% to 70% by weight, and wherein the liquid feed product containing a salt and the protein feedstuff are mixed under conditions sufficient to decrease the nitrogen solubility of the protein feedstuff.  A ruminant feed material with decreased nitrogen solubility, comprising a liquid feed product containing a salt contacted with a protein feedstuff, is also disclosed.
Patent NZ-517162-A (NZ)
Title: A ground engaging boundary element
Inventor: DRYSDALE WARWICK
IPC: A01G9/28
Filed: 2000-08-11
Abstract: Ground engaging boundary element (10) comprises opposing edge portions and earth engaging means (26) for anchoring element (10) in the earth. Earth engaging means (26) is formed at lower edge portion (18) of element (10). At least one of the opposing edge portions includes interlocking means (22) for joining to an adjacent ground engaging boundary element. Interlocking means (22) comprises complementary-shaped tongue or groove members and extends partially along each edge portion to adjacent lower edge portion (18). In use, earth engaging means (26) together with part of interlocking means (22) is embedded in the earth, and upper portion (24) of element (10) conceals interlocking means (22). The opposing edge portions of element (10) are also shaped to permit articulation of adjacent interlocked elements so as to provide for a non-linear elongated boundary structure.
Patent NZ-519440-A (NZ)
Title: Radio system with a press to talk (PTT) switch forming a part of a switch unit which is supported by the radio
Inventor: DAVIES JOHN
IPC: H04B1/38
Filed: 2000-12-15
Abstract: A radio system (1) comprising a radio and a press to talk (PTT) switch (16,17) which, when operated, sets the radio to a transmit mode, the switch forming part of a switch unit (12) which is supported on the radio by an interface arrangement (6) allowing detachment of the switch unit from the radio.
Patent NZ-521171-A (NZ)
Title: Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
Inventor: PICKAR JAMES H
IPC: A61P31/04
Filed: 2001-03-16
Abstract: Disclosed herein is a use of conjugated estrogens and medroxyprogesterone acetate in the manufacture of pharmaceutical packs comprising daily dosage units for the treatment or inhibition of menopausal or postmenopausal disorders in a perimenopausal, menopausal, or postmenopausal woman in need thereof, wherein each daily dosage unit comprises a combination of conjugated estrogens and a daily dosage of about 1. 5 mg of medroxyprogesterone acetate.
Patent NZ-523489-A (NZ)
Title: Method and composition for inhibition of microbial growth on the surfaces of fruit and vegetables in aqueous food transport and process streams
Inventor: HILGREN JOHN DENNIS
IPC: A01N59/00
Filed: 2001-06-25
Abstract: Disclosed are methods of reducing a microbial population on a surface of a fruit or vegetable within an aqueous transport stream, comprising contacting the aqueous transport stream with an antimicrobial composition of a mixture of organic acids and a chelating agent. The composition typically comprising 35-45% acetic acid, 5-15% octanoic acid, 3-8% hydrogen peroxide, 8-16% peroxyacetic acid, 1-5% peroxyoctanoic acid and 0.1-2% chelating agent. Wherein the microbial population comprises one or more of Escherichia coli, Listeria monocytogenes, or Salmonella javiana.
Patent NZ-527299-A (NZ)
Title: Guidance unit for conveyor belt
Inventor: HOVSTO KENNETH
IPC: B65G39/16
Filed: 2002-01-04
Abstract: The present invention relates to a belt guidance unit for centring a conveyor belt, which during operation is susceptible to lateral displacement away from a neutral position in its longitudinal direction. According to the invention the belt guidance unit can be employed on conveyor belts that move in one direction as well as in two opposite directions with only very slight alterations and the basic constructional features of the belt guidance unit are substantially identical in the two operational situations.
Patent NZ-527607-A (NZ)
Title: Channel blocking compounds for in vitro or nonhuman cells using a BK channel antagonist
Inventor: DALZIEL JULIE ELEANOR
IPC: A61K31/407
Filed: 2003-08-15
Abstract: A method of preventing repolarisation or hyperpolarisation of an in vitro cell or a nonhuman cell, wherein the cell contains a BK channel, is disclosed. The method involves the administration to the cell of a composition comprising a BK channel antagonist containing the moiety shown in structure (I). The BK channel antagonist compound is extracted from heterologous expression systems including bacteria, yeast, fungi, plants and animal cells. It can also be extracted from endophyte-infected seeds such as from perennial ryegrass of the species Lolium perenne.
Patent NZ-527735-A (NZ)
Title: Treatment or prevention of menopausal symptoms and osteoporosis
Inventor: KELLY GRAHAM EDMUND
IPC: A61K31/353
Filed: 1998-05-01
Abstract: Disclosed is the use of a therapeutically effective amount of an isoflavone in the manufacture of a medicament for the treatment or prevention of a medical condition selected from the group consisting of: Osteoporosis; and Menopausal symptoms; wherein for the treatment/prevention of osteoporosis said isoflavone is formononetin and wherein for the treatment/prevention of menopausal symptoms said isoflavone is either formononetin or daidzein, the medicament optionally containing one or more pharmaceutically acceptable adjuvants, carriers and/or excipients. (62) Divided out of 517339
Patent NZ-528507-A (NZ)
Title: Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
Inventor: BLANCHE FRANCIS
IPC: C12Q1/68
Filed: 2002-03-25
Abstract: Double stranded DNA target sequences capable of interacting with a third strand and forming a stable triple helix are described. Also described is a method for purifying a double stranded DNA molecule that consists of contacting a solution containing a double-stranded DNA molecule with a third DNA strand capable of forming by hybridisation a triple helix structure with a double stranded DNA target sequence borne by the double-stranded DNA molecule.
Patent NZ-530434-A (NZ)
Title: Intelligent microsensor module
Inventor: LIND MICHAEL A
IPC: G01D21/02
Filed: 2002-07-02
Abstract: An intelligent microsensor module (10, 100, 210, 300, 355, 410) is provided that can fuse data streams from a variety of sources and then locally determine the current state of the envrironment in which the intelligent microsensor is placed. The resultant state rather than raw data is communicated to the outside world when the microsensor is queried. The intelligent microsensor module (10, 100, 210, 300, 355, 410) of the present invention can locally determine and execute an action to be taken based on the determined state of the environment. The module (10, 100, 210, 300, 355, 410) can be readily reconfigured for multiple applications.
Patent NZ-538221-A (NZ)
Title: Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor for treating gastrointestinal inflammatory diseases
Inventor: GARST MICHAEL E
IPC: C07D401/12
Filed: 2003-07-15
Abstract: Benzimidazole derivative compounds of formulae (1), (2), (3) and (4) and their use as prodrugs of proton pump inhibitor are disclosed, wherein the substituents for the variables are as defined in the specification. These prodrugs hydrolyse slowly to provide benzimidazole-type proton pump inhibitors which inhibit exogenously or endogenously gastric acid secretion, have improved aqueous solubility and bioavailability in physiological fluids and can be used in the prevention and treatment of gastrointestinal inflammatory diseases in mammals. These compounds are suitable for use as anti-ulcer agents.
Patent NZ-538997-A (NZ)
Title: Item of furniture, with connecting plates switched between seat/back and front panel/worktop respectively
Inventor: MILINOV ILIAN VLADIMIROV
IPC: A47B85/04
Filed: 2003-01-23
Abstract: Disclosed is an item of transformable furniture, in particular to a chair that transforms into a desk and vice versa. An item of transformable furniture consisting of two substantially flat elements (5) and (6) connected with each other, which can switch over between a first position as a seat (6) and a back (5) and a second position as a front panel (6) and a worktop (5) and vice versa. The item of transformable furniture is provided with a supporting construction for the two substantially flat elements (5), (6). The supporting construction consists of two linked lateral vertical elements (1.1) located at a distance from one another, where the two substantially flat elements are located between the two linked lateral vertical elements (1.1).
Patent NZ-539101-A (NZ)
Title: Methods for treating post-surgical pain by administering a nerve growth factor antagonist and compositions containing the same
Inventor: SHELTON DAVID L
IPC: C07K16/22
Filed: 2003-10-08
Abstract: Disclosed is the use of an anti-NGF antibody in the manufacture of a medicament for treating post-surgical pain.
Patent NZ-543971-A (NZ)
Title: On-machine-seamable papermaking fabric
Inventor: RYDIN BJORN
IPC: D21F7/10
Filed: 2004-06-14
Abstract: A multi-layer on-machine-seamable press fabric having a single or double layer weave over the seam loops where the warp ends are not normally woven with CD yams. The CD yams woven into the layer(s) over the seam loops provide the fabric with substantially similar characteristics - including caliper and water permeability - in the seam area as in the remainder of the fabric. Hence, the press fabric provides a solution to the problem of non-uniformity in the seam area, which often results in sheet marking.
Patent NZ-544424-A (NZ)
Title: Compositions containing melon extracts
Inventor: SEBAGH JEAN-LOUIS
IPC: A61Q19/08
Filed: 2004-07-30
Abstract: Disclosed is a skin care composition comprising a safe and effective amount of an extract obtained from the melon species Cucumis melo, and magnesium ascorbyl phosphate (MAP), wherein the melon extract and the MAP in the composition help to minimise free radical damage to an individual's skin.